Our analysis revealed significantly increased expression levels of the TGM2 gene in tumor samples compared to controls for melanoma, diffuse large B-cell lymphoma, and pancreatic adenocarcinoma. The gene discussed is TGM2; the disease is pancreatic adenocarcinoma.